Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Scynexis Inc (NQ: SCYX ) 1.460 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Scynexis Inc < Previous 1 2 3 4 Next > SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024 August 09, 2024 SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 23, 2024 Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning! Via InvestorPlace 3 Stocks Under $10 With the Potential for Massive Gains July 22, 2024 Discover the growth potential of top small-cap stocks in the consumer finance, healthcare equipment and pharmaceutical industries. Via InvestorPlace 3 Dirt-Cheap Drug Developers With Blockbuster Potential July 11, 2024 These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent. Via InvestorPlace 7 Undervalued Biotech Stocks to Buy for Big-Time Returns July 01, 2024 The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive. Via InvestorPlace Should you consider SCYNEXIS INC (NASDAQ:SCYX) for growth investing? May 20, 2024 Exploring SCYNEXIS INC (NASDAQ:SCYX)'s growth characteristics. Via Chartmill SCYNEXIS: Q1 Earnings Insights May 11, 2023 Via Benzinga Looking Into SCYNEXIS's Return On Capital Employed April 03, 2023 Via Benzinga Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025 May 31, 2024 Read here about the top under-$10 growth stocks primed for financial success through strategic partnerships and innovative product offerings. Via InvestorPlace 3 Stocks Under $10 With Mammoth Growth Prospects May 23, 2024 Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors. Via InvestorPlace SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024 May 08, 2024 SCYX stock results show that SCYNEXIS beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023 March 28, 2024 SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace 5 Value Stocks To Watch In The Healthcare Sector January 29, 2024 Via Benzinga A Look Into Healthcare Sector Value Stocks January 08, 2024 Via Benzinga Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket January 04, 2024 Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 02, 2024 Via Benzinga Gold Moves Lower; TransCode Therapeutics Shares Surge September 25, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Intraday Session September 25, 2023 Via Benzinga Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session September 25, 2023 Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. Via Benzinga Nasdaq Turns Higher; SCYNEXIS Shares Plunge September 25, 2023 U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Why Are Antifungal Focused Scynexis Stock Plunging Today? September 25, 2023 Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga Via Benzinga U.S. Stocks Open Lower; Chicago Fed Index Falls In August September 25, 2023 U.S. stocks traded mostly lower this morning, with the Dow Jones trading falling around 80 points on Monday. Following the market opening Monday, the Dow traded down 0.26% to 33,875.83 while the NASDAQ... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session September 25, 2023 Via Benzinga Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now August 28, 2023 While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator. Via InvestorPlace Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket August 16, 2023 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 15, 2023 Via Benzinga Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher March 30, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session March 30, 2023 Via Benzinga Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 30, 2023 Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.